美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

輝瑞

22.83

+0.44501.99%

成交量：1,875.31萬

成交額：4.24億

市值：1,294.79億

市盈率：16.17

高：22.86

開：22.40

低：22.23

收：22.39

資料載入中...

總覽公司新聞公告

GLP-1研發風雲錄：MetaBio折戟沉沙，輝瑞緣何錯失良機？

輝瑞任命前 FDA 總監 Patrizia Cavazzoni 為首席醫療官

BUZZ-Summit Therapeutics 因與輝瑞公司的臨牀試驗合作而上漲

上市近一年未有銷售，慘遭輝瑞放棄

佰傲谷BioValley

輝瑞：退出基因療法賽道

輝瑞中國區副總裁、首席醫學事務官曹峻洋：中國在全球新藥臨牀研究和學術推動中的貢獻越來越大

每日经济新闻

特朗普警告製藥公司：關税即將到來應加快將海外生產轉移至美國

中國研究人員發現蝙蝠病毒進入人類細胞的途徑與 COVID 相同

跨國藥企營收前十榜單出爐！有人被“藥王”帶飛，有人在中國大賺……

国际金融报

輝瑞(PFE.US)1類新藥PF-07934040片在華獲批臨牀擬開發治療攜帶KRAS突變的晚期實體瘤

21健訊Daily | 國家醫保局發佈2025年度第一批重點事項清單；輝瑞公佈TALAPRO-2研究最新數據

21世纪经济报道

跨國藥企財報大PK：輝瑞重回第一，中國區業績哪家強？

经济观察报

“百億美元分子”榜單再擴容全球藥企TOP10重新洗牌

輝瑞公佈TALAPRO-2研究最新數據泰澤納與恩扎盧胺聯合療法有望成為改變臨牀實踐治療方案

中国网财经

【輝瑞旗下藥物Adcetris獲FDA擴大癌症治療批准】美國食品藥物管理局(FDA)擴大輝瑞公司旗下藥物Adcetris的批准範圍，允許其用於治療部分類型的淋巴瘤。該公司表示，繼先前兩種治療方法之後，Adcetris可與其他藥物合併使用，用於治療復發或難治性大B細胞淋巴瘤。

輝瑞依舊第一，GSK退出前10，禮來增速最高！——2024年各大MNC製藥業務TOP 10彙總

患者OS和PFS翻倍輝瑞(PFE.US)聯合公佈Padcev與Keytruda組合療法結果

SpringWorks 從輝瑞(PFE.US)引進的口服創新MEK抑制劑獲FDA批准上市

東方證券：降脂藥市場規模預計十年後將達465.8億美元國產藥物佔據主導地位

輝瑞下跌1.22%，報25.555美元/股

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/PFE/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PFE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PFE\",,,,,undefined,":{"symbol":"PFE","market":"US","secType":"STK","nameCN":"輝瑞","latestPrice":22.835,"timestamp":1745513906831,"preClose":22.39,"halted":0,"volume":18753550,"delay":0,"floatShares":5661835979,"shares":5671454767,"eps":1.411929,"marketStatus":"交易中","change":0.445,"latestTime":"04-24 12:58:26 EDT","open":22.4,"high":22.855,"low":22.23,"amount":424053791.06955,"amplitude":0.027914,"askPrice":22.84,"askSize":985,"bidPrice":22.83,"bidSize":2731,"shortable":3,"etf":0,"ttmEps":1.411929,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1745524800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":-819144000000,"exchange":"NYSE","adjPreClose":22.39,"dividendRate":0.073571,"preHourTrading":{"tag":"盘前","latestPrice":22.34,"preClose":22.39,"latestTime":"09:29 EDT","volume":117073,"amount":2631614.542711,"timestamp":1745501398596},"postHourTrading":{"tag":"盘后","latestPrice":22.42,"preClose":22.355,"latestTime":"19:59 EDT","volume":1068145,"amount":23916883.7069,"timestamp":1745452785507},"volumeRatio":0.830953,"impliedVol":0.3761,"impliedVolPercentile":0.892},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PFE\",,,,,undefined,":{"symbol":"PFE","floatShares":5661835979,"roa":"4.64%","roe":"9.06%","lyrEps":1.417902,"volumeRatio":0.830934,"shares":5671454767,"dividePrice":1.68,"high":22.855,"amplitude":0.027914,"preClose":22.39,"low":22.23,"week52Low":20.915,"pbRate":"1.47","psRate":"2.03","week52High":31.54,"institutionHeld":0.6486,"latestPrice":22.83,"committee":0.55347,"eps":1.411929,"divideRate":0.073587,"volume":18753130,"delay":0,"ttmEps":1.411929,"open":22.4,"prevYearClose":26.53,"prevWeekClose":22.14,"prevMonthClose":25.34,"prevQuarterClose":25.34,"fiveDayClose":22.04,"twentyDayClose":25.21,"sixtyDayClose":26.75,"earningDate":1745856000000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PFE\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514088406","title":"GLP-1研發風雲錄：MetaBio折戟沉沙，輝瑞緣何錯失良機？","url":"https://stock-news.laohu8.com/highlight/detail?id=2514088406","media":"药渡","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514088406?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 07:30","pubTimestamp":1740439838,"startTime":"0","endTime":"0","summary":"一个月后，MetaBio获得了GLP-1用于糖尿病疗法的全球独家许可。正式合作法律文件于1988年7月签署，MetaBio/辉瑞合作研发正式启动。2辉瑞退出GLP-1合作开发MetaBio/辉瑞联盟由一个联合研究委员会监督，辉瑞任命全球研发高级副总裁和中央研究院研发运营总监负责该项目，辉瑞参与者的资历表明了他们兴趣的强烈程度。辉瑞表示，将确定开发除注射以外的GLP-1给药途径，例如经鼻或经皮。当时MetaBio团队和创始人强烈反对辉瑞的观点。之后诺和诺德获得了哈贝纳的GLP-1专利权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225074833a25287d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225074833a25287d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0321505868.SGD","LU1883839398.USD","LU0306807586.USD","LU1057294990.SGD","SG9999013999.USD","SG9999001176.USD","IE000M9KFDE8.USD","LU0122379950.USD","BK4550","SG9999001176.SGD","IE00B19Z3B42.SGD","LU0985481810.HKD","BK4585","LU1066051498.USD","SG9999011175.SGD","LU0058720904.USD","BK4590","IE00B19Z3581.USD","LU0170899867.USD","BK4599","SG9999002232.USD","LU0225771236.USD","IE00BLSP4452.SGD","LU0225284248.USD","LU1023059063.AUD","SG9999003800.SGD","IE0002270589.USD","GLP","BK4588","BK4533","LU1894683348.USD","IE00BBT3K403.USD","PFE","IE00BLSP4239.USD","LU0306806265.USD","BK4144","BK4534","LU0868494617.USD","LU0456855351.SGD","BK4568","LU0234572021.USD","LU1894683264.USD","BK4581","BK4592","BK4007","SG9999002224.SGD","LU0289739699.SGD","LU1066053197.SGD","LU0321505439.SGD","SGXZ57979304.SGD"],"gpt_icon":1},{"id":"2514755647","title":"輝瑞任命前 FDA 總監 Patrizia Cavazzoni 為首席醫療官","url":"https://stock-news.laohu8.com/highlight/detail?id=2514755647","media":"路透中文","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514755647?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 00:13","pubTimestamp":1740413621,"startTime":"0","endTime":"0","summary":"辉瑞任命前 FDA 总监 Patrizia Cavazzoni 为首席医疗官路透社2月24日 - 辉瑞PFE.N周一表示，美国食品及药物管理局药物中心前负责人帕特里齐亚-卡瓦佐尼将加入该公司，担任首席医疗官。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL3T3PF182:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4588","LU0122379950.USD","LU1066053197.SGD","LU1066051498.USD","IE00BLSP4452.SGD","BK4568","LU1894683264.USD","LU0985481810.HKD","SGXZ57979304.SGD","BK4581","IE00BBT3K403.USD","LU1057294990.SGD","LU0225284248.USD","SG9999001176.USD","IE0002270589.USD","LU1883839398.USD","LU0225771236.USD","LU0868494617.USD","SG9999013999.USD","SG9999002224.SGD","LU0170899867.USD","BK4585","LU0234572021.USD","BK4533","LU0321505868.SGD","BK4550","SG9999011175.SGD","LU0306807586.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","PFE","LU1023059063.AUD","LU0058720904.USD","BK4592","LU0321505439.SGD","SG9999001176.SGD","IE000M9KFDE8.USD","LU0306806265.USD","LU0289739699.SGD","BK4007","BK4599","LU1894683348.USD","SG9999003800.SGD","SG9999002232.USD","LU0456855351.SGD","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2513742221","title":"BUZZ-Summit Therapeutics 因與輝瑞公司的臨牀試驗合作而上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2513742221","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513742221?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 19:41","pubTimestamp":1740397275,"startTime":"0","endTime":"0","summary":"2月24日 -  ** 药物开发商Summit Therapeutics SMMT.O股价盘前上涨6.2%至23.50美元 ** 该公司称，它正在与辉瑞PFE.N合作 ，研究其实验性药物ivonescimab与辉瑞的几种癌症靶向疗法在不同类型肿瘤中的联合应用。** 去年销售额超过 290 亿美元的全球最大药物 Keytruda 在这些研究中表现优异，在过去 12 个月中股价上涨了 5 倍。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL3T3PF0OX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0070302665.USD","LU0122379950.USD","IE00BBT3K403.USD","LU0234572021.USD","LU1585245621.USD","LU0265550359.USD","LU1061106388.HKD","SG9999015341.SGD","BK4592","LU0321505868.SGD","IE00BN8TJ469.HKD","LU0170899867.USD","LU1035773651.USD","LU2023250504.SGD","LU0456855351.SGD","LU0266013472.USD","LU1066051811.HKD","LU1093756168.USD","LU1934455194.USD","SG9999014559.SGD","PFE","LU2089984988.USD","LU0985320562.USD","IE000M9KFDE8.USD","SG9999001440.SGD","BK4581","LU0238689110.USD","IE0002141913.USD","LU2112291526.USD","IE00BFTCPJ56.SGD","LU2361045086.USD","SG9999014542.SGD","MRK","LU2106854487.HKD","SMMT","LU1934455277.USD","SG9999014567.USD","LU1983299246.USD","SG9999002224.SGD","LU1291159041.SGD","IE00BSNM7G36.USD","LU1894683348.USD","LU0289739699.SGD","LU0320765646.SGD","LU0861579265.USD","LU1699723380.USD","SG9999003800.SGD","BK4007","LU1066051498.USD","LU0225284248.USD"],"gpt_icon":1},{"id":"2513718706","title":"上市近一年未有銷售，慘遭輝瑞放棄","url":"https://stock-news.laohu8.com/highlight/detail?id=2513718706","media":"佰傲谷BioValley","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513718706?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 12:02","pubTimestamp":1740369720,"startTime":"0","endTime":"0","summary":"近日，根据媒体报道，辉瑞的一位发言人证实，辉瑞正在停止其血友病B基因治疗药物Beqvez的所有的开发和商业化活动。同时，辉瑞发言人证实，自获批以来，未有商业患者接受过Beqvez治疗。辉瑞退出病毒载体基因治疗辉瑞放弃Beqvez的决定，基本上标志着辉瑞退出了病毒载体递送的基因代替治疗领域。2023年7月，辉瑞将早期研发阶段的基因治疗卖给了阿斯利康旗下的罕见病部门Alexion。辉瑞随即放弃了该疗法的一切开发。2025年2月，辉瑞终止商业化的Beqvez。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-02-24/doc-inemqazp0162941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SG9999011175.SGD","LU0306807586.USD","IE00B19Z3581.USD","LU1057294990.SGD","LU1894683348.USD","BK4585","BK4592","BK4007","IE000M9KFDE8.USD","SG9999002224.SGD","BK4568","IE00BLSP4452.SGD","LU0058720904.USD","LU0122379950.USD","BK4581","LU0225284248.USD","LU0985481810.HKD","BK4550","BK4534","IE00B19Z3B42.SGD","LU1066053197.SGD","LU1883839398.USD","LU1066051498.USD","LU0321505868.SGD","IE00BBT3K403.USD","SG9999001176.USD","LU0234572021.USD","SG9999001176.SGD","LU0306806265.USD","SG9999002232.USD","LU1894683264.USD","BK4599","IE0002270589.USD","SG9999013999.USD","IE00BLSP4239.USD","LU0170899867.USD","LU0225771236.USD","LU1023059063.AUD","SG9999003800.SGD","BK4533","LU0289739699.SGD","SGXZ57979304.SGD","LU0868494617.USD","BK4588","PFE","LU0456855351.SGD","LU0321505439.SGD"],"gpt_icon":1},{"id":"2513791379","title":"輝瑞：退出基因療法賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2513791379","media":"谈思生物","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513791379?lang=zh_tw&edition=fundamental","pubTime":"2025-02-23 19:00","pubTimestamp":1740308434,"startTime":"0","endTime":"0","summary":"此前，辉瑞还终止了与Sangamo合作的A型血友病基因疗法，并撤回镰状细胞贫血疗法Oxbryta。关于此疗法的终止，辉瑞表示，主要原因是“患者和医生对血友病基因疗法兴趣有限”。其实，辉瑞在基因治疗领域早有动作。而且，辉瑞在2023年7月已将早期研发阶段的基因疗法以高达10亿美元的价格卖给了阿斯利康旗下的罕见病部门Alexion。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224104740a251503f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224104740a251503f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1894683264.USD","LU1894683348.USD","LU0306806265.USD","LU0170899867.USD","LU0456855351.SGD","LU0225771236.USD","LU0306807586.USD","LU0289739699.SGD","LU0321505868.SGD","LU0321505439.SGD","LU1883839398.USD","BK4568","BK4592","LU1057294990.SGD","LU1066051498.USD","IE000M9KFDE8.USD","IE00B19Z3581.USD","SG9999001176.SGD","LU0234572021.USD","LU1023059063.AUD","SG9999003800.SGD","IE00BLSP4239.USD","IE0002270589.USD","LU0985481810.HKD","BK4588","LU0058720904.USD","IE00BLSP4452.SGD","BK4007","BK4599","BK4533","PFE","LU0122379950.USD","LU0868494617.USD","SG9999002224.SGD","LU0225284248.USD","IE00B19Z3B42.SGD","SG9999002232.USD","BK4581","SG9999013999.USD","BK4550","SG9999001176.USD","BK4534","SGXZ57979304.SGD","LU1066053197.SGD","IE00BBT3K403.USD","BK4585","SG9999011175.SGD"],"gpt_icon":1},{"id":"2513627369","title":"輝瑞中國區副總裁、首席醫學事務官曹峻洋：中國在全球新藥臨牀研究和學術推動中的貢獻越來越大","url":"https://stock-news.laohu8.com/highlight/detail?id=2513627369","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513627369?lang=zh_tw&edition=fundamental","pubTime":"2025-02-22 17:43","pubTimestamp":1740217410,"startTime":"0","endTime":"0","summary":"2月13日—15日，美国临床肿瘤学会泌尿生殖系统肿瘤研讨会（ASCOGU）在美国旧金山召开。ASCOGU是单独针对泌尿生殖系统肿瘤的国际大会，每年来自世界各地的顶级医学专家都希望在这场学术盛会上分享自己的最新成果。今年大会上，辉瑞最受关注的研究之一是TALAPRO-2Ⅲ期临床试验关键结果。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202502223326758222.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502223326758222.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","IE00B19Z3B42.SGD","LU0122379950.USD","BK4585","BK4533","IE00BLSP4452.SGD","LU0234572021.USD","SG9999001176.USD","LU0170899867.USD","BK4550","LU0985481810.HKD","LU1883839398.USD","IE000M9KFDE8.USD","LU0456855351.SGD","SG9999011175.SGD","LU1066053197.SGD","IE00B19Z3581.USD","LU1066051498.USD","LU0306806265.USD","SG9999002232.USD","LU1023059063.AUD","LU1057294990.SGD","BK4534","BK4592","LU0225771236.USD","SGXZ57979304.SGD","SG9999003800.SGD","IE00BLSP4239.USD","BK4599","BK4581","IE00BBT3K403.USD","LU0225284248.USD","SG9999001176.SGD","LU0058720904.USD","LU1894683348.USD","PFE","LU0306807586.USD","LU0321505868.SGD","BK4007","LU0321505439.SGD","SG9999013999.USD","SG9999002224.SGD","BK4568","IE0002270589.USD","LU0868494617.USD","LU0289739699.SGD","LU1894683264.USD"],"gpt_icon":0},{"id":"2513851241","title":"特朗普警告製藥公司：關税即將到來 應加快將海外生產轉移至美國","url":"https://stock-news.laohu8.com/highlight/detail?id=2513851241","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513851241?lang=zh_tw&edition=fundamental","pubTime":"2025-02-22 08:14","pubTimestamp":1740183298,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["MRK","LU0456855351.SGD","LU0114720955.EUR","IE00BBT3K403.USD","LU0256863811.USD","LU2237438978.USD","LU0094547139.USD","SG9999014542.SGD","SG9999014575.USD","LU0238689110.USD","LU1894683264.USD","LU0820561909.HKD","LU0079474960.USD","LU0861579265.USD","IE00BLSP4239.USD","SG9999014914.USD","PFE","SG9999015945.SGD","LU1061106388.HKD","LU1934455194.USD","BK1574","IE00BFTCPJ56.SGD","LU0321505439.SGD","LU0096364046.USD","BK4585","LU0689472784.USD","IE0002270589.USD","IE00B1BXHZ80.USD","LU0985320562.USD","LU1548497426.USD","LU0203202063.USD","LU0320765489.SGD","LU1037948541.HKD","LU1066051225.USD","LU1868837300.USD","LU2023250504.SGD","LU2237443895.HKD","LU1934455277.USD","LU0256863902.USD","01477","LLY","IE00B19Z3581.USD","LU2324357040.USD","LU1551013425.SGD","LU1066053197.SGD","BK4007","SG9999014559.SGD","SG9999017495.SGD","BK4581","SG9999018857.SGD"],"gpt_icon":0},{"id":"2513245187","title":"中國研究人員發現蝙蝠病毒進入人類細胞的途徑與 COVID 相同","url":"https://stock-news.laohu8.com/highlight/detail?id=2513245187","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513245187?lang=zh_tw&edition=fundamental","pubTime":"2025-02-22 06:51","pubTimestamp":1740178309,"startTime":"0","endTime":"0","summary":"中国研究人员发现蝙蝠病毒进入人类细胞的途径与 COVID 相同Julie Steenhuysen/Nancy Lapid路透社2月21日 - 中国研究人员报告说，一种新发现的蝙蝠冠状病毒与导致COVID-19的SARS-CoV-2病毒一样，使用相同的细胞表面蛋白进入人体细胞，这使它有一天可能传播给人类。在进一步的实验中，研究人员发现了针对蝙蝠病毒的单克隆抗体和抗病毒药物。彭博社周五早些时候报导了这项研究，并称这篇发现蝙蝠病毒的论文推动了COVID疫苗生产商的股价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250221:nL3T3PC1X2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456855351.SGD","BK4548","BK4599","LU0985481810.HKD","SG9999003800.SGD","LU0234572021.USD","BK4139","IE0002270589.USD","SG9999011175.SGD","BK4581","IE000M9KFDE8.USD","LU0170899867.USD","SG9999001176.SGD","BK4568","LU0321505439.SGD","LU0058720904.USD","LU1894683264.USD","NVAX","LU0225284248.USD","BK4592","LU1894683348.USD","BK4550","IE00BLSP4452.SGD","LU0306806265.USD","BK4547","LU0289739699.SGD","BK4551","IE00BBT3K403.USD","LU1023059063.AUD","BK4585","PFE","LU1066053197.SGD","LU1057294990.SGD","LU0306807586.USD","SGXZ57979304.SGD","LU0122379950.USD","LU1883839398.USD","BK4007","IE00B19Z3581.USD","BK4588","BK4534","LU0321505868.SGD","MRNA","BK4532","SG9999002232.USD","LU0868494617.USD","BK4533","LU1066051498.USD","SG9999002224.SGD","IE00B19Z3B42.SGD"],"gpt_icon":1},{"id":"2512192364","title":"跨國藥企營收前十榜單出爐！有人被“藥王”帶飛，有人在中國大賺……","url":"https://stock-news.laohu8.com/highlight/detail?id=2512192364","media":"国际金融报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512192364?lang=zh_tw&edition=fundamental","pubTime":"2025-02-17 22:37","pubTimestamp":1739803075,"startTime":"0","endTime":"0","summary":"随着越来越多跨国药企发布2024年财报，全球药企业绩TOP10榜单也已于近日落定。“老大哥”强生依然稳坐第一，默沙东K药也保住了“药王”地位。阿斯利康在去年深陷风波，中国市场业绩却创下新高。罗氏、艾伯维、百时美施贵宝、赛诺菲旗下多款产品年销售额突破10亿甚至百亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202502173321357318.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502173321357318.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0098860793.USD","LU1066051498.USD","LU1057294990.SGD","LU1571399168.USD","JNJ","LU0912757837.SGD","LU1059921491.USD","IE00B3PB1722.GBP","LU0234570918.USD","SG9999002224.SGD","IE0002270589.USD","IE000M9KFDE8.USD","SG9999014575.USD","LU1989771016.USD","LU0321505439.SGD","LU0861579265.USD","LU1934455277.USD","LU1883839398.USD","MRK","LU0265550359.USD","LU1093756168.USD","LU0466842654.USD","IE00BN8TJ469.HKD","LU1116320737.USD","LU0456855351.SGD","LU0114720955.EUR","LU1674673691.USD","LU1935042991.SGD","LU1989772923.USD","SG9999013999.USD","LU0985320562.USD","LU2347655156.SGD","LU2133065610.SGD","PFE","SG9999015341.SGD","LU1778281490.HKD","LU1914381329.SGD","SGXZ57979304.SGD","LU1506573853.SGD","PSO","LU0345769128.USD","LU0345770308.USD","BK4599","LU0266013472.USD","LU2023250843.SGD","LU1280957306.USD","IE00BLSP4452.SGD","LU2324357040.USD","LU1116320901.HKD","COO"],"gpt_icon":1},{"id":"2512995562","title":"輝瑞(PFE.US)1類新藥PF-07934040片在華獲批臨牀 擬開發治療攜帶KRAS突變的晚期實體瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=2512995562","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512995562?lang=zh_tw&edition=fundamental","pubTime":"2025-02-17 11:16","pubTimestamp":1739762190,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，2月17日，中国国家药监局药品审评中心官网公示，辉瑞1类新药PF-07934040片获得临床试验默示许可，拟开发治疗携带KRAS突变的晚期实体瘤。本次PF-07934040在中国获批临床，意味着该产品即将在中国开展临床研究。研究表明，PF-07934040阻断了RAF-RBD与装载GTPgS的KRAS突变体的结合，表明其作用机制可能包括与KRAS on状态的结合和抑制RAF结合，调节下游信号传导。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1250495.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4592","IE00BBT3K403.USD","LU0170899867.USD","LU0058720904.USD","BK4588","LU0868494617.USD","LU0306806265.USD","BK4581","BK4568","LU1894683264.USD","IE00B19Z3B42.SGD","LU0122379950.USD","BK4599","LU0321505868.SGD","IE00B19Z3581.USD","LU0289739699.SGD","LU0225284248.USD","IE00BLSP4452.SGD","SG9999002224.SGD","BK4533","LU0306807586.USD","BK4585","IE00BLSP4239.USD","LU1883839398.USD","LU1057294990.SGD","LU0234572021.USD","LU0985481810.HKD","LU1066053197.SGD","LU1023059063.AUD","SG9999003800.SGD","SG9999011175.SGD","IE000M9KFDE8.USD","IE0002270589.USD","SG9999013999.USD","BK4534","SG9999002232.USD","LU0321505439.SGD","BK4007","LU0225771236.USD","PFE","SG9999001176.USD","LU0456855351.SGD","SG9999001176.SGD","BK4550","SGXZ57979304.SGD","LU1894683348.USD","LU1066051498.USD"],"gpt_icon":1},{"id":"2512296549","title":"21健訊Daily | 國家醫保局發佈2025年度第一批重點事項清單；輝瑞公佈TALAPRO-2研究最新數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2512296549","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512296549?lang=zh_tw&edition=fundamental","pubTime":"2025-02-17 07:34","pubTimestamp":1739748855,"startTime":"0","endTime":"0","summary":"政策动向国家医保局发布2025年度第一批重点事项清单2月14日晚，国家医保局发布《医保领域“高效办成一件事”2025年度第一批重点事项清单》。针对定点医药机构的即时结算，针对医药企业的集采药品耗材、国谈药的直接结算均作为2025年重点事项出现在清单中。此外，还有针对参保人员门诊慢特病10个病种跨省费用直接结算等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202502173320366548.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502173320366548.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0321505439.SGD","BK4534","IE0002270589.USD","IE00BLSP4452.SGD","LU1066053197.SGD","LU0225771236.USD","LU1057294990.SGD","LU0868494617.USD","LU0058720904.USD","LU0225284248.USD","BK4585","LU1066051498.USD","SG9999003800.SGD","BK4550","IE000M9KFDE8.USD","LU1883839398.USD","SG9999013999.USD","IE00BBT3K403.USD","IE00B19Z3581.USD","SG9999002232.USD","LU0985481810.HKD","LU0306807586.USD","BK4599","IE00BLSP4239.USD","LU0306806265.USD","LU0122379950.USD","BK4007","LU0289739699.SGD","BK4588","LU0456855351.SGD","LU1894683348.USD","BK4592","LU1894683264.USD","SG9999001176.SGD","BK4533","SGXZ57979304.SGD","IE00B19Z3B42.SGD","BK4568","LU1023059063.AUD","LU0170899867.USD","PFE","SG9999001176.USD","LU0234572021.USD","SG9999002224.SGD","LU0321505868.SGD","BK4581","SG9999011175.SGD"],"gpt_icon":1},{"id":"2511798251","title":"跨國藥企財報大PK：輝瑞重回第一，中國區業績哪家強？","url":"https://stock-news.laohu8.com/highlight/detail?id=2511798251","media":"经济观察报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511798251?lang=zh_tw&edition=fundamental","pubTime":"2025-02-16 13:08","pubTimestamp":1739682480,"startTime":"0","endTime":"0","summary":"2024年的前十名“玩家”有了变化，葛兰素史克掉出了榜单，新入局的是礼来。前者的带状疱疹疫苗增长乏力，后者的减肥神药势头正猛。　　2月以来，跨国药企密集公布2024年财报。经济观察报统计，截至2月13日，2024年全球制药企业TOP50榜单中前10名的药企都公布了2024年业绩。从业绩表现看，重新洗牌后的格局是“几家欢喜几家愁”。　　强生公司在2023年以534.6亿美元的处方药销售额占据全球首位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-02-16/doc-ineksafe5146634.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-02-16/doc-ineksafe5146634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["PK","PFE"],"gpt_icon":1},{"id":"2511967398","title":"“百億美元分子”榜單再擴容 全球藥企TOP10重新洗牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2511967398","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511967398?lang=zh_tw&edition=fundamental","pubTime":"2025-02-15 17:31","pubTimestamp":1739611893,"startTime":"0","endTime":"0","summary":"【“百亿美元分子”榜单再扩容 全球药企TOP10重新洗牌】在爆款大单品的带动下，全球药企营收TOP10的榜单座次也发生了变化，礼来凭借替尔泊肽成为第九，而葛兰素史克则掉出榜单。机构预测，2030年全球抗肥胖药物市场整体规模有望达到1000亿美元。随着司美格鲁肽和替尔泊肽的销量狂飙，2025年的头部格局将如何重构，仍然充满了悬念。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202502153320197347.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502153320197347.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4592","IE0002270589.USD","IE00BJT1NW94.SGD","LU0208291251.USD","LU0868494617.USD","LU1934455194.USD","SG9999014575.USD","BMS","LU0320765489.SGD","LU1974910355.USD","IE00B4R5TH58.HKD","IE00BLSP4239.USD","LU2468319806.SGD","LU1989771016.USD","BK4581","LU1116320737.USD","MRK","LU0306807586.USD","PFE","LU1571399168.USD","LU0965508806.USD","LU2361045086.USD","LU1093756168.USD","LU1430594728.SGD","LU2089984988.USD","LU0203345920.USD","SG9999014567.USD","IE00B1BXHZ80.USD","BK4559","IE00B19Z3581.USD","LU1093756325.SGD","IE00B2B36J28.USD","LU0265550359.USD","LU2106854487.HKD","LU0234572021.USD","LU2112291526.USD","LU0211331839.USD","SG9999003800.SGD","IE00BLSP4452.SGD","LU0306806265.USD","IE0002141913.USD","LU0965509101.SGD","LU0965509283.SGD","SG9999013999.USD","LU1061106388.HKD","SG9999015358.SGD","LU1883839398.USD","LU2023250504.SGD","LU0861579265.USD","LU0006306889.USD"],"gpt_icon":1},{"id":"2511650208","title":"輝瑞公佈TALAPRO-2研究最新數據 泰澤納與恩扎盧胺聯合療法有望成為改變臨牀實踐治療方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2511650208","media":"中国网财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511650208?lang=zh_tw&edition=fundamental","pubTime":"2025-02-14 17:53","pubTimestamp":1739526780,"startTime":"0","endTime":"0","summary":"辉瑞期待与各国监管机构继续合作，基于TALAPRO-2研究的最新数据，考虑在未来更新泰泽纳的获批信息。TALAPRO-2研究结果表明，泰泽纳与恩扎卢胺的联合疗法有望成为改变临床实践的治疗方案，帮助mCRPC患者延长生存期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502141800519622d58a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502141800519622d58a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0306806265.USD","IE0002270589.USD","IE000M9KFDE8.USD","BK4533","LU0456855351.SGD","LU1066051498.USD","BK4581","LU1023059063.AUD","IE00BLSP4452.SGD","LU0321505868.SGD","BK4007","IE00BBT3K403.USD","LU1057294990.SGD","LU0321505439.SGD","IE00B19Z3B42.SGD","LU1066053197.SGD","BK4550","IE00B19Z3581.USD","LU0225771236.USD","BK4585","SG9999013999.USD","LU0868494617.USD","BK4588","LU1894683348.USD","LU1894683264.USD","PFE","SG9999002224.SGD","BK4534","BK4568","IE00BLSP4239.USD","LU0225284248.USD","LU1883839398.USD","BK4599","LU0985481810.HKD","SG9999003800.SGD","LU0170899867.USD","SG9999011175.SGD","LU0234572021.USD","BK4592","LU0058720904.USD","LU0289739699.SGD","SGXZ57979304.SGD","SG9999002232.USD","LU0122379950.USD","SG9999001176.USD","LU0306807586.USD","SG9999001176.SGD"],"gpt_icon":1},{"id":"2511552508","title":"【輝瑞旗下藥物Adcetris獲FDA擴大癌症治療批准】美國食品藥物管理局(FDA)擴大輝瑞公司旗下藥物Adcetris的批准範圍，允許其用於治療部分類型的淋巴瘤。該公司表示，繼先前兩種治療方法之後，Adcetris可與其他藥物合併使用，用於治療復發或難治性大B細胞淋巴瘤。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511552508","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511552508?lang=zh_tw&edition=fundamental","pubTime":"2025-02-13 10:21","pubTimestamp":1739413307,"startTime":"0","endTime":"0","summary":"美国食品药物管理局(FDA)扩大辉瑞公司旗下药物Adcetris的批准范围，允许其用于治疗部分类型的淋巴瘤。该公司表示，继先前两种治疗方法之后，Adcetris可与其他药物合并使用，用于治疗复发或难治性大B细胞淋巴瘤。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/13102148128552.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4534","BK4588","LU0122379950.USD","LU1066053197.SGD","LU1066051498.USD","IE00BLSP4452.SGD","BK4568","LU1894683264.USD","LU0985481810.HKD","SGXZ57979304.SGD","BK4581","IE00BBT3K403.USD","LU1057294990.SGD","LU0225284248.USD","SG9999001176.USD","IE0002270589.USD","LU1883839398.USD","LU0225771236.USD","LU0868494617.USD","SG9999013999.USD","SG9999002224.SGD","LU0170899867.USD","BK4585","LU0234572021.USD","BK4533","LU0321505868.SGD","BK4550","SG9999011175.SGD","LU0306807586.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","PFE","LU1023059063.AUD","LU0058720904.USD","BK4592","LU0321505439.SGD","SG9999001176.SGD","IE000M9KFDE8.USD","LU0306806265.USD","LU0289739699.SGD","BK4007","BK4599","LU1894683348.USD","SG9999003800.SGD","SG9999002232.USD","LU0456855351.SGD","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2511534602","title":"輝瑞依舊第一，GSK退出前10，禮來增速最高！——2024年各大MNC製藥業務TOP 10彙總","url":"https://stock-news.laohu8.com/highlight/detail?id=2511534602","media":"药时代","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511534602?lang=zh_tw&edition=fundamental","pubTime":"2025-02-13 07:02","pubTimestamp":1739401362,"startTime":"0","endTime":"0","summary":"正文共：6535字16图预计阅读时间：17分钟表：MNC制药业务收入TOP 10来源：各大药企财报从总排名来看，辉瑞依旧排名第一，同比增长7%，GSK退出前10，礼来以32%的最高增速新进入榜单第九名。K药作为默沙东的核心产品，K药2024年销售额达294.82亿美元，同比增长18%，约占默沙东全年总营收的46%。受此影响，默沙东自2025年2月起阶段性调整中国市场的发货节奏，预计将于年中逐步恢复常态。自身免疫业务整体收入178.28亿美元，同比下降1.2%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213070454a243c0d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213070454a243c0d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0417517546.SGD","LU0225771236.USD","LU0058720904.USD","LU1023059063.AUD","SG9999001176.SGD","LU0985481810.HKD","LU1814569148.SGD","LU2089984988.USD","BK4516","PFE","SG9999002232.USD","SG9999014880.SGD","LU0006306889.USD","LU0321505868.SGD","BK4588","LU2237443465.HKD","LU0256863811.USD","SG9999014914.USD","LU0321505439.SGD","LU2361044949.HKD","LU0234572021.USD","LU1868836757.USD","SG9999001176.USD","BK4592","LU0109391861.USD","LU2237443382.USD","SG9999018857.SGD","IE00BK4W5M84.HKD","GSK.UK","LU1720051108.HKD","LU0823416689.USD","IE00BLSP4452.SGD","SG9999015986.USD","IE00BLSP4239.USD","SGXZ57979304.SGD","LU1069344957.HKD","LU0096364046.USD","BK4532","GSK","LU2360106947.USD","IE000M9KFDE8.USD","LU0456855351.SGD","LU2602419157.SGD","LU2063271972.USD","LU1868836914.USD","LU0225284248.USD","IE00BJJMRZ35.SGD","LU1983299246.USD","LLY","LU2106854487.HKD"],"gpt_icon":1},{"id":"2510631737","title":"患者OS和PFS翻倍 輝瑞(PFE.US)聯合公佈Padcev與Keytruda組合療法結果","url":"https://stock-news.laohu8.com/highlight/detail?id=2510631737","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510631737?lang=zh_tw&edition=fundamental","pubTime":"2025-02-12 14:15","pubTimestamp":1739340941,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，辉瑞与安斯泰来公司日前宣布，将在美国临床肿瘤学会泌尿生殖系统癌症研讨会上，公布3期临床试验EV-302的长期随访结果。这项研究评估了抗体偶联药物Padcev与Keytruda联用，治疗既往未接受治疗的局部晚期或转移性尿路上皮癌患者的效果。结果显示，与化疗相比，Padcev加Keytruda可将患者死亡风险降低49%。联合治疗组的中位PFS为12.5个月，而化疗组为6.3个月。安全性特征与以往结果一致，未发现新的安全问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1248781.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0306806265.USD","LU2361044949.HKD","MRK","BK4534","LU1883839398.USD","BK4516","BK4581","LU0070302665.USD","LU1116320901.HKD","LU1934455863.HKD","LU1585245621.USD","IE00BFTCPJ56.SGD","LU0289739699.SGD","LU0170899867.USD","LU1941712264.USD","SG9999015341.SGD","IE00BSNM7G36.USD","PFS","IE00BLSP4239.USD","LU0965509010.AUD","BK4211","LU1116320737.USD","IE00BBT3K403.USD","LU2361045086.USD","LU1989772840.SGD","IE00B2B36J28.USD","LU2089984988.USD","SG9999001176.USD","LU1061106388.HKD","IE0009355771.USD","LU2361044865.SGD","LU0861579265.USD","LU0238689110.USD","LU0321505868.SGD","LU0965508806.USD","LU1037948897.HKD","BK4559","LU1989772923.USD","SG9999015358.SGD","LU0203347892.USD","SG9999013999.USD","BK4568","SG9999001440.SGD","PFE","SG9999003800.SGD","LU0985320562.USD","LU0265550946.USD","BK4550","LU0106261372.USD","LU1894683348.USD"],"gpt_icon":0},{"id":"2510143623","title":"SpringWorks 從輝瑞(PFE.US)引進的口服創新MEK抑制劑獲FDA批准上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2510143623","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510143623?lang=zh_tw&edition=fundamental","pubTime":"2025-02-12 13:47","pubTimestamp":1739339263,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，当地时间2月11日，SpringWorks Therapeutics 宣布，美国 FDA 已批准其 MEK 抑制剂 Gomekli上市，用于治疗患有 1 型神经纤维瘤病  且有症状的丛状神经纤维瘤  且无法完全切除的 2 岁及以上成人和儿童患者。新闻稿指出，这是首个也是唯一一个获批用于治疗成人和儿童 NF1-PN 的药物。该产品是 SpringWorks 从辉瑞引进的。数据显示，Gomekli 达到了客观缓解率  的主要终点，成人患者的 ORR 为 41%，儿童患者的 ORR 为 52%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1248766.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"SpringWorks 从辉瑞(PFE.US)引进的口服创新MEK抑制剂获FDA批准上市","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0456855351.SGD","BK4599","LU0225771236.USD","LU0985481810.HKD","SG9999003800.SGD","SG9999013999.USD","LU0234572021.USD","IE0002270589.USD","SG9999011175.SGD","BK4581","IE000M9KFDE8.USD","LU0170899867.USD","SG9999001176.SGD","BK4568","LU0321505439.SGD","LU0058720904.USD","LU1894683264.USD","LU0225284248.USD","BK4592","LU1894683348.USD","BK4550","IE00BLSP4452.SGD","IE00BLSP4239.USD","LU0306806265.USD","LU0289739699.SGD","IE00BBT3K403.USD","LU1023059063.AUD","BK4585","PFE","LU1066053197.SGD","LU1057294990.SGD","LU0306807586.USD","SGXZ57979304.SGD","LU0122379950.USD","LU1883839398.USD","BK4007","IE00B19Z3581.USD","BK4588","BK4534","LU0321505868.SGD","SG9999002232.USD","SG9999001176.USD","LU0868494617.USD","BK4533","LU1066051498.USD","SG9999002224.SGD","IE00B19Z3B42.SGD"],"gpt_icon":1},{"id":"2510392437","title":"東方證券：降脂藥市場規模預計十年後將達465.8億美元 國產藥物佔據主導地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2510392437","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510392437?lang=zh_tw&edition=fundamental","pubTime":"2025-02-12 10:51","pubTimestamp":1739328695,"startTime":"0","endTime":"0","summary":"财中社2月12日电东方证券发表研究报告称：全球心血管疾病发病率上升，推动降脂药市场稳定增长。从全球来看，2023年降脂药市场规模为331.2亿美元，预计十年后将达到465.8亿美元，期间CAGR 3.45%。2023年，我国等级医院及零售终端降脂药销售额已突破250亿元，未来有望稳定增长。传统降脂药的进口替代是大势所趋，联合用药成势头。传统他汀类、胆固醇抑制剂类、贝特类降脂药中的国产药物逐渐占据主要市场地位。PCSK9新药来势汹汹，国产药物后来居上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021210523198824bc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021210523198824bc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PFE"],"gpt_icon":1},{"id":"2510862332","title":"輝瑞下跌1.22%，報25.555美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2510862332","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510862332?lang=zh_tw&edition=fundamental","pubTime":"2025-02-12 00:47","pubTimestamp":1739292475,"startTime":"0","endTime":"0","summary":"2月12日，辉瑞(PFE)盘中下跌1.22%，截至00:47，报25.555美元/股，成交3.04亿美元。财务数据显示，截至2024年12月31日，辉瑞收入总额636.27亿美元，同比增长6.84%；归母净利润80.31亿美元，同比增长279.0%。大事提醒：2月10日，辉瑞获Guggenheim Investments重申评级Buy，目标价33美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/12004748092443.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1894683348.USD","SG9999001176.SGD","IE000M9KFDE8.USD","LU0985481810.HKD","LU0306806265.USD","LU0321505439.SGD","LU1057294990.SGD","LU1066051498.USD","LU0225284248.USD","BK4599","LU0321505868.SGD","BK4568","LU1066053197.SGD","LU1894683264.USD","PFE","SG9999013999.USD","LU0170899867.USD","BK4581","IE00BBT3K403.USD","LU0122379950.USD","LU0234572021.USD","BK4550","BK4534","BK4592","SG9999002232.USD","LU0868494617.USD","LU1883839398.USD","BK4533","SG9999003800.SGD","LU0289739699.SGD","IE0002270589.USD","IE00BLSP4239.USD","LU0058720904.USD","BK4585","LU0306807586.USD","SG9999001176.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","SG9999011175.SGD","LU1023059063.AUD","LU0225771236.USD","BK4007","BK4588","SG9999002224.SGD","LU0456855351.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":7,"totalSize":338,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PFE\",params:#limit:5,,,undefined,":[{"date":"2025-05-09","symbol":"PFE","amount":0.43,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-09","defaultRemindTime":1746797400000,"name":"辉瑞","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-13","payableDate":"2025-05-09","currency":"USD","dateTimestamp":1746763200000,"payDate":"2025-06-13"},{"date":"2025-04-29","symbol":"PFE","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":0.64,"defaultRemindTime":1745913600000,"name":null,"time":"盤前","dateTimestamp":1745899200000,"actualEps":null},{"market":"US","date":"2025-02-04","symbol":"PFE","fiscalQuarterEnding":"2024/12","expectedEps":0.48,"name":null,"time":"盤前","type":"earning","dateTimestamp":1738645200000,"reportTimeType":"pre","actualEps":0.63},{"date":"2025-01-24","symbol":"PFE","amount":0.43,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-01-24","defaultRemindTime":1737729000000,"name":"辉瑞","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-07","payableDate":"2025-01-24","currency":"USD","dateTimestamp":1737694800000,"payDate":"2025-03-07"},{"date":"2024-11-08","symbol":"PFE","amount":0.42,"announcedDate":"2024-10-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-08","defaultRemindTime":1731076200000,"name":"辉瑞","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-02","payableDate":"2024-11-08","currency":"USD","dateTimestamp":1731042000000,"payDate":"2024-12-02"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PFE\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-06","recordDate":"2015-05-08","paymentDate":"2015-06-02","value":0.28,"currency":"USD"},{"executeDate":"2015-08-05","recordDate":"2015-08-07","paymentDate":"2015-09-02","value":0.28,"currency":"USD"},{"executeDate":"2015-11-04","recordDate":"2015-11-06","paymentDate":"2015-12-01","value":0.28,"currency":"USD"},{"executeDate":"2016-02-03","recordDate":"2016-02-05","paymentDate":"2016-03-02","value":0.3,"currency":"USD"},{"executeDate":"2016-05-11","recordDate":"2016-05-13","paymentDate":"2016-06-01","value":0.3,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PFE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1739,"buy":0.1739,"hold":0.6087,"sell":0,"strongSell":0.0435,"meanLabel":"HOLD","meanPercent":0.6087,"analysts":23,"updateTime":1744171200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PFE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PFE","date":"2025-04-23","current":15.910581,"percent":0.614507,"low":-542.819255,"twenty":8.349508,"median":14.155517,"eighty":21.276479,"high":75.601276,"avg":-4.805668,"sd":102.782905,"marketCap":127777875900},"quantilePoints":[{"date":"2020-04-24","current":12.939645,"twenty":10.625441,"median":19.371343,"eighty":23.832105,"marketCap":207370746006},{"date":"2020-05-01","current":13.263029,"twenty":10.659859,"median":19.371343,"eighty":23.832105,"marketCap":208813132148},{"date":"2020-05-08","current":13.132045,"twenty":10.703825,"median":19.371343,"eighty":23.832105,"marketCap":206750912323},{"date":"2020-05-15","current":13.322569,"twenty":10.745223,"median":19.371343,"eighty":23.832105,"marketCap":209750522551},{"date":"2020-05-22","current":13.230835,"twenty":10.787158,"median":19.371343,"eighty":23.832105,"marketCap":208306265775},{"date":"2020-05-29","current":13.474282,"twenty":10.807956,"median":19.371343,"eighty":23.832105,"marketCap":212139101065},{"date":"2020-06-05","current":12.698073,"twenty":10.911556,"median":19.371343,"eighty":23.832105,"marketCap":199918466806},{"date":"2020-06-12","current":11.907751,"twenty":10.952149,"median":19.371343,"eighty":23.832105,"marketCap":187475639197},{"date":"2020-06-19","current":11.79132,"twenty":10.990736,"median":19.371343,"eighty":23.832105,"marketCap":185642544058},{"date":"2020-06-26","current":11.304425,"twenty":11.04062,"median":19.371343,"eighty":23.832105,"marketCap":177976873478},{"date":"2020-07-02","current":12.175896,"twenty":11.132308,"median":19.371343,"eighty":23.832105,"marketCap":191697312850},{"date":"2020-07-10","current":11.935977,"twenty":11.180285,"median":19.371343,"eighty":23.832105,"marketCap":187920025897},{"date":"2020-07-17","current":12.789807,"twenty":11.246327,"median":19.371343,"eighty":23.832105,"marketCap":201362723582},{"date":"2020-07-24","current":13.287287,"twenty":11.312153,"median":19.371343,"eighty":23.832105,"marketCap":209195039175},{"date":"2020-07-31","current":15.06661,"twenty":11.377811,"median":19.371343,"eighty":23.832105,"marketCap":213750002853},{"date":"2020-08-07","current":15.060409,"twenty":11.412076,"median":19.370131,"eighty":23.832105,"marketCap":213662028579},{"date":"2020-08-14","current":14.907651,"twenty":11.412076,"median":19.340601,"eighty":23.832105,"marketCap":211494845454},{"date":"2020-08-21","current":15.228835,"twenty":11.412076,"median":19.300578,"eighty":23.832105,"marketCap":216051486896},{"date":"2020-08-28","current":14.848898,"twenty":11.412076,"median":19.284357,"eighty":23.832105,"marketCap":210661313483},{"date":"2020-09-04","current":14.241781,"twenty":11.412076,"median":19.262235,"eighty":23.832105,"marketCap":202048149782},{"date":"2020-09-11","current":14.128192,"twenty":11.412076,"median":19.231048,"eighty":23.832105,"marketCap":200436654638},{"date":"2020-09-18","current":14.347537,"twenty":11.412076,"median":19.195321,"eighty":23.832105,"marketCap":203548507330},{"date":"2020-09-25","current":14.120358,"twenty":11.412076,"median":19.118706,"eighty":23.832105,"marketCap":200325517042},{"date":"2020-10-02","current":14.249615,"twenty":11.412076,"median":19.118706,"eighty":23.832105,"marketCap":202159287378},{"date":"2020-10-09","current":14.410207,"twenty":11.412076,"median":19.029529,"eighty":23.832105,"marketCap":204437608099},{"date":"2020-10-16","current":14.864565,"twenty":11.412076,"median":18.964703,"eighty":23.832105,"marketCap":210883588675},{"date":"2020-10-23","current":14.954654,"twenty":11.412076,"median":18.846107,"eighty":23.832105,"marketCap":212161671031},{"date":"2020-10-30","current":24.71582,"twenty":11.412076,"median":18.835814,"eighty":23.849364,"marketCap":197158095552},{"date":"2020-11-06","current":25.363625,"twenty":11.412076,"median":18.835814,"eighty":23.928031,"marketCap":202325636203},{"date":"2020-11-13","current":26.910527,"twenty":11.412076,"median":18.835814,"eighty":23.944104,"marketCap":214665276653},{"date":"2020-11-20","current":25.572666,"twenty":11.412076,"median":18.835814,"eighty":23.985435,"marketCap":203993155183},{"date":"2020-11-27","current":25.941971,"twenty":11.412076,"median":18.852,"eighty":24.03861,"marketCap":206939105380},{"date":"2020-12-04","current":28.109028,"twenty":11.412076,"median":18.852,"eighty":24.12255,"marketCap":224225718803},{"date":"2020-12-11","current":28.652535,"twenty":11.412076,"median":18.852,"eighty":24.165559,"marketCap":228561268150},{"date":"2020-12-18","current":26.255533,"twenty":11.412076,"median":18.852,"eighty":24.219428,"marketCap":209440383850},{"date":"2020-12-24","current":25.969843,"twenty":11.412076,"median":18.871195,"eighty":24.242916,"marketCap":207161441244},{"date":"2020-12-31","current":25.649314,"twenty":11.412076,"median":18.871195,"eighty":24.268549,"marketCap":204604578809},{"date":"2021-01-08","current":25.872291,"twenty":11.412076,"median":19.222906,"eighty":24.29085,"marketCap":206383265720},{"date":"2021-01-15","current":25.572666,"twenty":11.412076,"median":19.376594,"eighty":24.303923,"marketCap":203993155183},{"date":"2021-01-22","current":25.468145,"twenty":11.412076,"median":19.45935,"eighty":24.334718,"marketCap":203159395693},{"date":"2021-01-29","current":25.015224,"twenty":11.412076,"median":19.60201,"eighty":24.366926,"marketCap":199546437904},{"date":"2021-02-05","current":21.192184,"twenty":11.412076,"median":19.647309,"eighty":24.37168,"marketCap":194099209237},{"date":"2021-02-12","current":21.070808,"twenty":11.412076,"median":19.703213,"eighty":24.37168,"marketCap":192987529917},{"date":"2021-02-19","current":20.900882,"twenty":11.412076,"median":19.735619,"eighty":24.37168,"marketCap":191431178869},{"date":"2021-02-26","current":20.394673,"twenty":11.412076,"median":19.846528,"eighty":24.37168,"marketCap":186794811653},{"date":"2021-03-05","current":20.942753,"twenty":11.409861,"median":19.979527,"eighty":24.37434,"marketCap":191814678195},{"date":"2021-03-12","current":21.279731,"twenty":11.409861,"median":20.149239,"eighty":24.37434,"marketCap":194901052046},{"date":"2021-03-19","current":21.639062,"twenty":11.409861,"median":20.299846,"eighty":24.37434,"marketCap":198192168838},{"date":"2021-03-26","current":22.077568,"twenty":11.412076,"median":20.33376,"eighty":24.37168,"marketCap":202208446957},{"date":"2021-04-01","current":22.10802,"twenty":11.412076,"median":20.387438,"eighty":24.37168,"marketCap":202487355160},{"date":"2021-04-09","current":22.290731,"twenty":11.409861,"median":20.482136,"eighty":24.37434,"marketCap":204160804376},{"date":"2021-04-16","current":23.490533,"twenty":11.409861,"median":20.580846,"eighty":24.37434,"marketCap":215149787562},{"date":"2021-04-23","current":23.545346,"twenty":11.409861,"median":20.672898,"eighty":24.37434,"marketCap":215651822327},{"date":"2021-04-30","current":23.539255,"twenty":11.409861,"median":20.714304,"eighty":24.37434,"marketCap":215596040687},{"date":"2021-05-07","current":20.670699,"twenty":11.409861,"median":20.745571,"eighty":24.37434,"marketCap":220783733257},{"date":"2021-05-14","current":20.973664,"twenty":11.409861,"median":20.760105,"eighty":24.37434,"marketCap":224019708557},{"date":"2021-05-21","current":20.936979,"twenty":11.409861,"median":20.760105,"eighty":24.37434,"marketCap":223627869986},{"date":"2021-05-28","current":20.297602,"twenty":11.409861,"median":20.716502,"eighty":24.37434,"marketCap":216798683468},{"date":"2021-06-04","current":20.517715,"twenty":11.409861,"median":20.692277,"eighty":24.37434,"marketCap":219149714893},{"date":"2021-06-11","current":21.041795,"twenty":11.409861,"median":20.672898,"eighty":24.37434,"marketCap":224747408760},{"date":"2021-06-18","current":20.339528,"twenty":11.409861,"median":20.65811,"eighty":24.37434,"marketCap":217246498978},{"date":"2021-06-25","current":20.428622,"twenty":11.409861,"median":20.596327,"eighty":24.37434,"marketCap":218198106935},{"date":"2021-07-02","current":20.821681,"twenty":11.409861,"median":20.580846,"eighty":24.37434,"marketCap":222396377335},{"date":"2021-07-09","current":20.758792,"twenty":11.409861,"median":20.579237,"eighty":24.37434,"marketCap":221724654071},{"date":"2021-07-16","current":21.146611,"twenty":11.409861,"median":20.579237,"eighty":24.367449,"marketCap":225866947533},{"date":"2021-07-23","current":21.843636,"twenty":11.409861,"median":20.579237,"eighty":24.367449,"marketCap":233311880376},{"date":"2021-07-30","current":18.78624,"twenty":11.409861,"median":20.542088,"eighty":24.365286,"marketCap":239637274446},{"date":"2021-08-06","current":19.777992,"twenty":11.409861,"median":20.503796,"eighty":24.357982,"marketCap":252288062585},{"date":"2021-08-13","current":21.30858,"twenty":11.409861,"median":20.491511,"eighty":24.357982,"marketCap":271812251498},{"date":"2021-08-20","current":21.414068,"twenty":11.409861,"median":20.491511,"eighty":24.357982,"marketCap":273157856704},{"date":"2021-08-27","current":20.482258,"twenty":11.409861,"median":20.482258,"eighty":24.357982,"marketCap":261271677389},{"date":"2021-09-03","current":20.587746,"twenty":11.409861,"median":20.467021,"eighty":24.357982,"marketCap":262617282595},{"date":"2021-09-10","current":20.038329,"twenty":11.409861,"median":20.455205,"eighty":24.357982,"marketCap":255608922150},{"date":"2021-09-17","current":19.291122,"twenty":11.409861,"median":20.423381,"eighty":24.357982,"marketCap":246077551944},{"date":"2021-09-24","current":19.313099,"twenty":11.409861,"median":20.369394,"eighty":24.357982,"marketCap":246357886362},{"date":"2021-10-01","current":18.86917,"twenty":11.409861,"median":20.329046,"eighty":24.357982,"marketCap":240695131123},{"date":"2021-10-08","current":18.658194,"twenty":11.409861,"median":20.299846,"eighty":24.357982,"marketCap":238003920712},{"date":"2021-10-15","current":18.236242,"twenty":11.409861,"median":20.236119,"eighty":24.357982,"marketCap":232621499890},{"date":"2021-10-22","current":18.970263,"twenty":11.409861,"median":20.177063,"eighty":24.357982,"marketCap":241984669444},{"date":"2021-10-29","current":19.225192,"twenty":11.409861,"median":20.091518,"eighty":24.357982,"marketCap":245236548691},{"date":"2021-11-05","current":14.025377,"twenty":11.409861,"median":19.896498,"eighty":24.357982,"marketCap":272541120985},{"date":"2021-11-12","current":14.36434,"twenty":11.409861,"median":19.777992,"eighty":24.357982,"marketCap":279127855918},{"date":"2021-11-19","current":14.673406,"twenty":11.409861,"median":19.717295,"eighty":24.357982,"marketCap":285133623178},{"date":"2021-11-26","current":15.597715,"twenty":11.409861,"median":19.677911,"eighty":24.357982,"marketCap":303094796292},{"date":"2021-12-03","current":15.675703,"twenty":11.409861,"median":19.602804,"eighty":24.357982,"marketCap":304610270273},{"date":"2021-12-10","current":15.245322,"twenty":11.409861,"median":19.422982,"eighty":24.357982,"marketCap":296247099042},{"date":"2021-12-17","current":17.180594,"twenty":11.409861,"median":19.291122,"eighty":24.357982,"marketCap":333853305249},{"date":"2021-12-23","current":16.958182,"twenty":11.409861,"median":19.150471,"eighty":24.357982,"marketCap":329531397968},{"date":"2021-12-31","current":17.05639,"twenty":11.409861,"median":18.970263,"eighty":24.357982,"marketCap":331439772611},{"date":"2022-01-07","current":16.094531,"twenty":11.412076,"median":18.877961,"eighty":24.349074,"marketCap":312748926840},{"date":"2022-01-14","current":15.872119,"twenty":11.412076,"median":18.781561,"eighty":24.349074,"marketCap":308427019560},{"date":"2022-01-21","current":15.248211,"twenty":11.412076,"median":18.550508,"eighty":24.349074,"marketCap":296303227708},{"date":"2022-01-28","current":15.693034,"twenty":11.412076,"median":18.2758,"eighty":24.349074,"marketCap":304947042269},{"date":"2022-02-04","current":15.308868,"twenty":11.412076,"median":17.658635,"eighty":24.349074,"marketCap":297481929694},{"date":"2022-02-11","current":12.967895,"twenty":11.412076,"median":17.063675,"eighty":24.349074,"marketCap":285021365846},{"date":"2022-02-18","current":12.393303,"twenty":11.412076,"median":16.913411,"eighty":24.304908,"marketCap":272392416000},{"date":"2022-02-25","current":12.209204,"twenty":11.412076,"median":16.666775,"eighty":24.28572,"marketCap":268346093596},{"date":"2022-03-04","current":12.447145,"twenty":11.412076,"median":16.350479,"eighty":24.223896,"marketCap":273575805814},{"date":"2022-03-11","current":12.861624,"twenty":11.412076,"median":16.242465,"eighty":24.163866,"marketCap":282685627097},{"date":"2022-03-18","current":13.946431,"twenty":11.412076,"median":16.098985,"eighty":24.106879,"marketCap":306528616134},{"date":"2022-03-25","current":13.503809,"twenty":11.412076,"median":16.055537,"eighty":24.034221,"marketCap":296800226739},{"date":"2022-04-01","current":13.19423,"twenty":11.412076,"median":15.959151,"eighty":23.843315,"marketCap":289995977509},{"date":"2022-04-08","current":14.115293,"twenty":11.412076,"median":15.941662,"eighty":23.723395,"marketCap":310240024805},{"date":"2022-04-14","current":13.590799,"twenty":11.412076,"median":15.900125,"eighty":23.573362,"marketCap":298712164539},{"date":"2022-04-22","current":12.314103,"twenty":11.412076,"median":15.858587,"eighty":23.512736,"marketCap":270651665649},{"date":"2022-04-29","current":12.554603,"twenty":11.412076,"median":15.790815,"eighty":22.633009,"marketCap":275937611331},{"date":"2022-05-06","current":11.045779,"twenty":11.377811,"median":15.703367,"eighty":22.453679,"marketCap":275768910937},{"date":"2022-05-13","current":11.219095,"twenty":11.321022,"median":15.657458,"eighty":22.360096,"marketCap":280095918385},{"date":"2022-05-20","current":11.792185,"twenty":11.321022,"median":15.601352,"eighty":22.291941,"marketCap":294403702678},{"date":"2022-05-27","current":12.115813,"twenty":11.321022,"median":15.49568,"eighty":22.218192,"marketCap":302483392631},{"date":"2022-06-03","current":11.956247,"twenty":11.321022,"median":15.456215,"eighty":22.152127,"marketCap":298499656613},{"date":"2022-06-10","current":11.230332,"twenty":11.312153,"median":15.377007,"eighty":22.082449,"marketCap":280376463175},{"date":"2022-06-17","current":10.457221,"twenty":11.246327,"median":15.324755,"eighty":21.997212,"marketCap":261074981620},{"date":"2022-06-24","current":11.594413,"twenty":11.225837,"median":15.248211,"eighty":21.941859,"marketCap":289466114373},{"date":"2022-07-01","current":11.756227,"twenty":11.225837,"median":15.219326,"eighty":21.878005,"marketCap":293505959350},{"date":"2022-07-08","current":11.949505,"twenty":11.225837,"median":15.168412,"eighty":21.831359,"marketCap":298331329739},{"date":"2022-07-15","current":11.630372,"twenty":11.225837,"median":15.075933,"eighty":21.74118,"marketCap":290363857701},{"date":"2022-07-22","current":11.513506,"twenty":11.225837,"median":15.043129,"eighty":21.652794,"marketCap":287446191885},{"date":"2022-07-29","current":9.669931,"twenty":11.215862,"median":15.01571,"eighty":21.581005,"marketCap":283406346908},{"date":"2022-08-05","current":9.432538,"twenty":11.166146,"median":14.985989,"eighty":21.512019,"marketCap":276448836115},{"date":"2022-08-12","current":9.595842,"twenty":11.131952,"median":14.907651,"eighty":21.443472,"marketCap":281234949148},{"date":"2022-08-19","current":9.412007,"twenty":11.0455,"median":14.852815,"eighty":21.354014,"marketCap":275847091412},{"date":"2022-08-26","current":8.965822,"twenty":11.017001,"median":14.805812,"eighty":21.321791,"marketCap":262770311697},{"date":"2022-09-02","current":8.751347,"twenty":10.97228,"median":14.699402,"eighty":21.273106,"marketCap":256484477671},{"date":"2022-09-09","current":9.161147,"twenty":10.950031,"median":14.660888,"eighty":21.227382,"marketCap":268494910542},{"date":"2022-09-16","current":8.814541,"twenty":10.914418,"median":14.476794,"eighty":21.18126,"marketCap":258336553768},{"date":"2022-09-23","current":8.441124,"twenty":10.844223,"median":14.421958,"eighty":21.144824,"marketCap":247392467740},{"date":"2022-09-30","current":8.379846,"twenty":10.790275,"median":14.374955,"eighty":21.126333,"marketCap":245596515161},{"date":"2022-10-07","current":8.104092,"twenty":10.768631,"median":14.316202,"eighty":21.072492,"marketCap":237514728556},{"date":"2022-10-14","current":8.2075,"twenty":10.734827,"median":14.245698,"eighty":21.041795,"marketCap":240545398533},{"date":"2022-10-21","current":8.607725,"twenty":10.699722,"median":14.16736,"eighty":21.017687,"marketCap":252275213814},{"date":"2022-10-28","current":9.082634,"twenty":10.659445,"median":14.112734,"eighty":20.988442,"marketCap":266193846300},{"date":"2022-11-04","current":8.901792,"twenty":10.621799,"median":14.006768,"eighty":20.960547,"marketCap":265015252420},{"date":"2022-11-11","current":8.974968,"twenty":10.584832,"median":13.879672,"eighty":20.925828,"marketCap":267193771961},{"date":"2022-11-18","current":9.093754,"twenty":10.560165,"median":13.798038,"eighty":20.887265,"marketCap":270730160119},{"date":"2022-11-25","current":9.278533,"twenty":10.525451,"median":13.674906,"eighty":20.874204,"marketCap":276231208365},{"date":"2022-12-02","current":9.599068,"twenty":10.488819,"median":13.589588,"eighty":20.863738,"marketCap":285773843078},{"date":"2022-12-09","current":9.751793,"twenty":10.453561,"median":13.569587,"eighty":20.837349,"marketCap":290320627853},{"date":"2022-12-16","current":9.691457,"twenty":10.410193,"median":13.503809,"eighty":20.82389,"marketCap":288524367201},{"date":"2022-12-23","current":9.772533,"twenty":10.366422,"median":13.455198,"eighty":20.795407,"marketCap":290938092452},{"date":"2022-12-30","current":9.661289,"twenty":10.34012,"median":13.432165,"eighty":20.776578,"marketCap":287626236875},{"date":"2023-01-06","current":9.600953,"twenty":10.304932,"median":13.41682,"eighty":20.763011,"marketCap":285829976224},{"date":"2023-01-13","current":9.022105,"twenty":10.285152,"median":13.368208,"eighty":20.746667,"marketCap":268597100595},{"date":"2023-01-20","current":8.505479,"twenty":10.273114,"median":13.35752,"eighty":20.71844,"marketCap":253216618764},{"date":"2023-01-27","current":8.256593,"twenty":10.265725,"median":13.294343,"eighty":20.680003,"marketCap":245807043575},{"date":"2023-02-03","current":7.883547,"twenty":10.235468,"median":13.287287,"eighty":20.672898,"marketCap":247322638500},{"date":"2023-02-10","current":7.85134,"twenty":10.235468,"median":13.287287,"eighty":20.672898,"marketCap":246312241883},{"date":"2023-02-17","current":7.731459,"twenty":10.235468,"median":13.287287,"eighty":20.672898,"marketCap":242551321143},{"date":"2023-02-24","current":7.47789,"twenty":10.235468,"median":13.287287,"eighty":20.672898,"marketCap":234596365426},{"date":"2023-03-03","current":7.370423,"twenty":10.227112,"median":13.287287,"eighty":20.672898,"marketCap":231224920654},{"date":"2023-03-10","current":7.055188,"twenty":10.223818,"median":13.287287,"eighty":20.672898,"marketCap":221335349321},{"date":"2023-03-17","current":7.214731,"twenty":10.211706,"median":13.287287,"eighty":20.672898,"marketCap":226340534916},{"date":"2023-03-24","current":7.266907,"twenty":10.211706,"median":13.287287,"eighty":20.672898,"marketCap":227977411603},{"date":"2023-03-31","current":7.340674,"twenty":10.20121,"median":13.286569,"eighty":20.672898,"marketCap":230291616573},{"date":"2023-04-06","current":7.475613,"twenty":10.20121,"median":13.286569,"eighty":20.672898,"marketCap":234524918348},{"date":"2023-04-14","current":7.461219,"twenty":10.211706,"median":13.287287,"eighty":20.672898,"marketCap":234073366159},{"date":"2023-04-21","current":7.169751,"twenty":10.195184,"median":13.287287,"eighty":20.672898,"marketCap":224929434324},{"date":"2023-04-28","current":6.970042,"twenty":10.128354,"median":13.287287,"eighty":20.672898,"marketCap":218664147697},{"date":"2023-05-05","current":7.427817,"twenty":10.119305,"median":13.287287,"eighty":20.672898,"marketCap":215785502490},{"date":"2023-05-12","current":7.301526,"twenty":10.119305,"median":13.287287,"eighty":20.672898,"marketCap":212116640951},{"date":"2023-05-19","current":7.08894,"twenty":10.119305,"median":13.287287,"eighty":20.672898,"marketCap":205940800089},{"date":"2023-05-26","current":7.351278,"twenty":10.119305,"median":13.287287,"eighty":20.672898,"marketCap":213561964566},{"date":"2023-06-02","current":7.388199,"twenty":10.119305,"median":13.287287,"eighty":20.672898,"marketCap":214634572900},{"date":"2023-06-09","current":7.596126,"twenty":10.119305,"median":13.287287,"eighty":20.672898,"marketCap":220675051411},{"date":"2023-06-16","current":7.72438,"twenty":10.119305,"median":13.287287,"eighty":20.672898,"marketCap":224400954045},{"date":"2023-06-23","current":7.526169,"twenty":10.131582,"median":13.294343,"eighty":20.672898,"marketCap":218642740884},{"date":"2023-06-30","current":7.018983,"twenty":10.140189,"median":13.296923,"eighty":20.672898,"marketCap":203908489562},{"date":"2023-07-07","current":6.923765,"twenty":10.140189,"median":13.296923,"eighty":20.672898,"marketCap":201142289122},{"date":"2023-07-14","current":7.007324,"twenty":10.140189,"median":13.296923,"eighty":20.672898,"marketCap":203569771141},{"date":"2023-07-21","current":7.145294,"twenty":10.140189,"median":13.296923,"eighty":20.672898,"marketCap":207577939125},{"date":"2023-07-28","current":7.034529,"twenty":9.937466,"median":13.296923,"eighty":20.672898,"marketCap":204360114124},{"date":"2023-08-04","current":9.20159,"twenty":9.822311,"median":13.299503,"eighty":20.676451,"marketCap":197585745700},{"date":"2023-08-11","current":9.391966,"twenty":9.731394,"median":13.299503,"eighty":20.676451,"marketCap":201673675840},{"date":"2023-08-18","current":9.599683,"twenty":9.677882,"median":13.299503,"eighty":20.676451,"marketCap":206133983900},{"date":"2023-08-25","current":9.507656,"twenty":9.664306,"median":13.299503,"eighty":20.676451,"marketCap":204157898051},{"date":"2023-09-01","current":9.302568,"twenty":9.625087,"median":13.299503,"eighty":20.676451,"marketCap":199754049586},{"date":"2023-09-08","current":9.013342,"twenty":9.597778,"median":13.311036,"eighty":20.680003,"marketCap":193543494059},{"date":"2023-09-15","current":8.979161,"twenty":9.565322,"median":13.322569,"eighty":20.683556,"marketCap":192809519315},{"date":"2023-09-22","current":8.637348,"twenty":9.536302,"median":13.322569,"eighty":20.683556,"marketCap":185469771874},{"date":"2023-09-29","current":8.437519,"twenty":9.506079,"median":13.322569,"eighty":20.683556,"marketCap":181178842601},{"date":"2023-10-06","current":8.800366,"twenty":9.474085,"median":13.322569,"eighty":20.683556,"marketCap":188970266807},{"date":"2023-10-13","current":8.655753,"twenty":9.433517,"median":13.322569,"eighty":20.683556,"marketCap":185864989044},{"date":"2023-10-20","current":8.200879,"twenty":9.395121,"median":13.326394,"eighty":20.687108,"marketCap":176097478988},{"date":"2023-10-27","current":8.192991,"twenty":9.371624,"median":13.352857,"eighty":20.691307,"marketCap":175928100201},{"date":"2023-11-03","current":16.428331,"twenty":9.363832,"median":13.357974,"eighty":20.691307,"marketCap":172201766885},{"date":"2023-11-10","current":15.987936,"twenty":9.363832,"median":13.388235,"eighty":20.691307,"marketCap":167585546506},{"date":"2023-11-17","current":16.036417,"twenty":9.363832,"median":13.431944,"eighty":20.691307,"marketCap":168093723702},{"date":"2023-11-24","current":16.429651,"twenty":9.363832,"median":13.449665,"eighty":20.691307,"marketCap":172215605406},{"date":"2023-12-01","current":16.413491,"twenty":9.363832,"median":13.493575,"eighty":20.691307,"marketCap":172046213007},{"date":"2023-12-08","current":15.422325,"twenty":9.363982,"median":13.545766,"eighty":20.690984,"marketCap":161656812549},{"date":"2023-12-15","current":14.075632,"twenty":9.363982,"median":13.586961,"eighty":20.690984,"marketCap":147540779319},{"date":"2023-12-22","current":15.249949,"twenty":9.363982,"median":13.63957,"eighty":20.690984,"marketCap":159849960296},{"date":"2023-12-29","current":15.508514,"twenty":9.363832,"median":13.71586,"eighty":20.691307,"marketCap":162560238676},{"date":"2024-01-05","current":15.670117,"twenty":9.363681,"median":13.842132,"eighty":20.691631,"marketCap":164254162664},{"date":"2024-01-12","current":15.298429,"twenty":9.363681,"median":13.918956,"eighty":20.691631,"marketCap":160358137492},{"date":"2024-01-19","current":15.13144,"twenty":9.363531,"median":14.025377,"eighty":20.691954,"marketCap":158607749372},{"date":"2024-01-26","current":14.79746,"twenty":9.363681,"median":14.11067,"eighty":20.691631,"marketCap":155106973131},{"date":"2024-02-02","current":72.718555,"twenty":9.363681,"median":14.114013,"eighty":20.691631,"marketCap":154090618738},{"date":"2024-02-09","current":73.46466,"twenty":9.363681,"median":14.114013,"eighty":20.691631,"marketCap":155671614460},{"date":"2024-02-16","current":73.30478,"twenty":9.363681,"median":14.114013,"eighty":20.691631,"marketCap":155332829662},{"date":"2024-02-23","current":73.411367,"twenty":9.363681,"median":14.114013,"eighty":20.691631,"marketCap":155558686194},{"date":"2024-03-01","current":70.777931,"twenty":9.363832,"median":14.115293,"eighty":20.698091,"marketCap":149978434968},{"date":"2024-03-08","current":71.390842,"twenty":9.363832,"median":14.115293,"eighty":20.70875,"marketCap":151277194005},{"date":"2024-03-15","current":75.170971,"twenty":9.363832,"median":14.115293,"eighty":20.724066,"marketCap":159287286515},{"date":"2024-03-22","current":73.915003,"twenty":9.363832,"median":14.115293,"eighty":20.724066,"marketCap":156625892109},{"date":"2024-03-28","current":74.235676,"twenty":9.363832,"median":14.115293,"eighty":20.724066,"marketCap":157305397063},{"date":"2024-04-05","current":71.21601,"twenty":9.363681,"median":14.114013,"eighty":20.719408,"marketCap":150906725405},{"date":"2024-04-12","current":70.387606,"twenty":9.363681,"median":14.114013,"eighty":20.719408,"marketCap":149151337604},{"date":"2024-04-19","current":67.848949,"twenty":9.363681,"median":14.114013,"eighty":20.740378,"marketCap":143771923378},{"date":"2024-04-26","current":67.501554,"twenty":9.363832,"median":14.115293,"eighty":20.761487,"marketCap":143035793010},{"date":"2024-05-03","current":-507.612925,"twenty":9.362812,"median":14.112734,"eighty":20.779592,"marketCap":156852393760},{"date":"2024-05-10","current":-516.778602,"twenty":9.30426,"median":14.025377,"eighty":20.779592,"marketCap":159684587865},{"date":"2024-05-17","current":-530.349083,"twenty":9.281927,"median":13.893323,"eighty":20.779592,"marketCap":163877866610},{"date":"2024-05-24","current":-526.131231,"twenty":9.204745,"median":13.825068,"eighty":20.779592,"marketCap":162574550243},{"date":"2024-05-31","current":-517.145371,"twenty":9.159833,"median":13.705621,"eighty":20.779592,"marketCap":159797919723},{"date":"2024-06-07","current":-528.148464,"twenty":9.089983,"median":13.590799,"eighty":20.779592,"marketCap":163197875462},{"date":"2024-06-14","current":-507.059203,"twenty":9.054359,"median":13.569959,"eighty":20.766987,"marketCap":156681293629},{"date":"2024-06-21","current":-508.709667,"twenty":8.999235,"median":13.526836,"eighty":20.756696,"marketCap":157191286990},{"date":"2024-06-28","current":-509.809976,"twenty":8.978992,"median":13.485271,"eighty":20.724066,"marketCap":157531282564},{"date":"2024-07-05","current":-507.976127,"twenty":8.959703,"median":13.452431,"eighty":20.680003,"marketCap":156964623274},{"date":"2024-07-12","current":-525.581076,"twenty":8.928182,"median":13.425447,"eighty":20.602616,"marketCap":162404552456},{"date":"2024-07-15","current":-530.349083,"twenty":8.925357,"median":13.41895,"eighty":20.602616,"marketCap":163877866610},{"date":"2024-08-02","current":-66.929122,"twenty":8.913428,"median":13.358168,"eighty":20.552583,"marketCap":173681072323},{"date":"2024-08-09","current":-62.803141,"twenty":8.84518,"median":13.330218,"eighty":20.552583,"marketCap":162974150040},{"date":"2024-08-16","current":-62.693956,"twenty":8.820285,"median":13.285852,"eighty":20.552583,"marketCap":162690815287},{"date":"2024-08-23","current":-62.846815,"twenty":8.780071,"median":13.272201,"eighty":20.552583,"marketCap":163087483941},{"date":"2024-08-30","current":-62.715793,"twenty":8.751347,"median":13.255982,"eighty":20.552583,"marketCap":162747482238},{"date":"2024-09-06","current":-62.257216,"twenty":8.721486,"median":13.227307,"eighty":20.552583,"marketCap":161557476274},{"date":"2024-09-13","current":-63.67662,"twenty":8.701558,"median":13.199081,"eighty":20.552583,"marketCap":165240828066},{"date":"2024-09-20","current":-64.768468,"twenty":8.637348,"median":13.170562,"eighty":20.552583,"marketCap":168074175598},{"date":"2024-09-27","current":-63.261717,"twenty":8.534957,"median":13.144103,"eighty":20.552583,"marketCap":164164156004},{"date":"2024-10-04","current":-61.885988,"twenty":8.497937,"median":13.113626,"eighty":20.552583,"marketCap":160594138113},{"date":"2024-10-11","current":-64.069685,"twenty":8.452614,"median":13.081087,"eighty":20.552583,"marketCap":166260833177},{"date":"2024-10-18","current":-63.916826,"twenty":8.441124,"median":13.067436,"eighty":20.552583,"marketCap":165864164523},{"date":"2024-10-25","current":-62.541097,"twenty":8.39325,"median":13.032891,"eighty":20.552583,"marketCap":162294146632},{"date":"2024-10-31","current":38.008971,"twenty":8.358781,"median":13.016245,"eighty":20.579237,"marketCap":161614143225},{"date":"2024-11-08","current":36.5982,"twenty":8.35569,"median":13.041929,"eighty":20.599471,"marketCap":155615546361},{"date":"2024-11-15","current":34.678994,"twenty":8.35569,"median":13.069751,"eighty":20.698158,"marketCap":147455080710},{"date":"2024-11-22","current":33.492817,"twenty":8.35569,"median":13.111712,"eighty":20.759745,"marketCap":142411459579},{"date":"2024-11-29","current":34.932222,"twenty":8.35569,"median":13.132162,"eighty":20.796701,"marketCap":148531808817},{"date":"2024-12-06","current":34.252503,"twenty":8.35569,"median":13.149456,"eighty":20.842645,"marketCap":145641643899},{"date":"2024-12-13","current":33.812685,"twenty":8.35569,"median":13.187835,"eighty":20.875948,"marketCap":143771537187},{"date":"2024-12-20","current":34.345798,"twenty":8.35569,"median":13.196655,"eighty":20.936979,"marketCap":146038333201},{"date":"2024-12-27","current":35.398696,"twenty":8.35569,"median":13.196655,"eighty":20.973673,"marketCap":150515255329},{"date":"2025-01-03","current":35.465335,"twenty":8.35569,"median":13.196655,"eighty":21.011398,"marketCap":150798604831},{"date":"2025-01-10","current":35.798531,"twenty":8.352599,"median":13.19423,"eighty":21.041795,"marketCap":152215352340},{"date":"2025-01-17","current":35.305401,"twenty":8.352599,"median":13.19423,"eighty":21.133948,"marketCap":150118566027},{"date":"2025-01-24","current":35.238762,"twenty":8.352599,"median":13.19423,"eighty":21.157872,"marketCap":149835216525},{"date":"2025-01-31","current":35.86517,"twenty":8.352599,"median":13.212001,"eighty":21.24665,"marketCap":152498701841},{"date":"2025-02-07","current":18.226666,"twenty":8.352599,"median":13.255982,"eighty":21.274853,"marketCap":146378352604},{"date":"2025-02-14","current":18.092594,"twenty":8.352599,"median":13.287287,"eighty":21.274853,"marketCap":145301624497},{"date":"2025-02-21","current":18.276061,"twenty":8.352599,"median":13.357974,"eighty":21.274853,"marketCap":146775041906},{"date":"2025-02-28","current":18.417188,"twenty":8.352599,"median":13.431944,"eighty":21.274853,"marketCap":147908439913},{"date":"2025-03-07","current":18.517123,"twenty":8.349508,"median":13.483929,"eighty":21.276479,"marketCap":148711012463},{"date":"2025-03-14","current":18.065486,"twenty":8.349508,"median":13.545766,"eighty":21.276479,"marketCap":145083914598},{"date":"2025-03-21","current":18.495256,"twenty":8.349508,"median":13.586961,"eighty":21.276479,"marketCap":148535400347},{"date":"2025-03-28","current":17.661945,"twenty":8.349508,"median":13.722721,"eighty":21.276479,"marketCap":141843083722},{"date":"2025-04-04","current":17.153485,"twenty":8.349508,"median":13.955057,"eighty":21.276479,"marketCap":137759636290},{"date":"2025-04-11","current":15.246757,"twenty":8.352599,"median":14.075632,"eighty":21.274853,"marketCap":122446708419},{"date":"2025-04-17","current":15.564545,"twenty":8.352599,"median":14.115293,"eighty":21.274853,"marketCap":124998863064},{"date":"2025-04-23","current":15.910581,"twenty":8.349508,"median":14.155517,"eighty":21.276479,"marketCap":127777875900}],"updateTime":1745513907001}}}